N/A
Completed N=512
My Diabetes, My Community
Source: ClinicalTrials.gov NCT04970810 ↗Enrolled (actual)
512
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcomePrimary: Mean Change in Percent of Hemoglobin A1C — -1.1; -0.8; -0.8 percentage of hemoglobin A1C — p=0.8
Summary
Older adults with diabetes are a highly vulnerable population that suffers the highest rates of cardiovascular and microvascular complications as well as adverse drug events such as hypoglycemia. Investigators will conduct a 12-month pragmatic clinical trial evaluating the impact of scalable interventions that are designed to support personalized goal setting and self-care through remote delivery of clinical and socioeconomic risk assessment, telephonic care management, and community resource linkage. This highly personalized approach to diabetes care has to potential to improve quality of life of this high-risk population while avoiding adverse drug events.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Change in Percent of Hemoglobin A1C |
-1.1; -0.8; -0.8 | 0.8 |
| SECONDARY Number of Participants With Documentation of Diabetes Goal at Baseline and Month 12 |
52; 60; 43; 43; 165; 156 | 0.2 |
| SECONDARY Personalized A1C Goals |
6.6; 6.7; 7.1; 7.1 | 0.7 |
| SECONDARY Number of Participants Who Achieved Personalized A1C Goals |
5; 1; 38; 34 | 0.2 |
| SECONDARY Diabetes Empowerment Scale (DES) |
-0.1; -0.2; 0.03 | 0.9 |
Eligibility Criteria
Inclusion Criteria
- History of type 2 diabetes
- Seen in clinic within past year
- A1C>7.5%
- Community dwelling
- Access to personal email address OR internet access
- Speaks and reads English
- Resides in the target geographic region (zip codes)
Exclusion Criteria
- Unable to consent to study for themselves
- Prior participation in CRxCaregiver, CRxHunger, or My Diabetes GOAL trials
Data sourced from ClinicalTrials.gov (NCT04970810). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.